Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (323) clinical trials

The Memory Health Center at Summit Research Network, is enrolling participants in the Clarity AD Research Study.  This research study will evaluate whether an investigational study drug is safe and effective in slowing the progression of Alzheimer’s. Study participation may last to up 23 months with the option to participate …

Phase N/A

The Memory Health Center at Summit Research Network, is enrolling participants in a new mild Alzheimer’s clinical trial. This trial will evaluate the safety and effectiveness of the study medication, azeligaron in the treatment of mild Alzheimer’s disease in patients who also have glucose intolerance or Type 2 Diabetes: those …

Phase

Study participation will last about a year.   Following a screening period of up to 6 weeks, qualified participants will be randomly assigned to the oral investigational medication, C0R388, or a placebo (an inactive substance).   During the treatment period, the participants will visit the research center 9 times over a 48 …

Phase

People who may develop Alzheimer's Disease are asked to participate in a research study being conducted by New York University School of Medicine.

Phase N/A

This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in …

Phase

PET Imaging of Cyclooxygenases in Dementia

Study Description: This pilot/exploratory study will examine whether cyclooxygenase 1 (COX-1) and COX-2 are elevated in the brain of individuals with dementia compared to healthy volunteers. Objectives: Primary Objective: To determine whether COX-1 or COX-2 is elevated in the brains of individuals with dementia compared to healthy volunteers. Endpoints: Primary …

Phase

PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

The objectives of this study are to establish 1-year safety and to investigate the effect of PTI-125 on biomarkers, cognition and neuropsychiatric symptoms during 12-month repeat-dose oral administration in mild-to-moderate AD patients, 50-85 years of age.

Phase

Multimodal Imaging in the Study of Disorientation in the Hospital

This is an experimental cross-sectional study which primarily aims at identifying characteristic features of spatial disorientation among people with mild cognitive impairment and dementia. The features of interest are motion and physiological related changes that occur during instances of spatial disorientation, which will be derived from wearable sensors. Additionally, brain …

Phase N/A

Effect of Hearing Loss and Vestibular Decline on Cognitive Function in Older Subjects

The world population has been growing and aging dramatically, with a rising prevalence of dementia. Worldwide, around 50 million people have dementia, with 10 million new cases added every year. Despite the epidemic scale of dementia, until now no cure or disease-modifying therapy has been identified. Therefore, the World Health …

Phase N/A